Predicted to enable protein serine/threonine phosphatase activity. Acts upstream of or within cellular response to leukemia inhibitory factor. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in 2-cell stage embryo and 4-cell stage embryo. Orthologous to human LRRC2 (leucine rich repeat containing 2). [provided by Alliance of Genome Resources, Apr 2022]